SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:3dfbc946-373e-4806-8db2-280f27e704cc"
 

Search: onr:"swepub:oai:lup.lub.lu.se:3dfbc946-373e-4806-8db2-280f27e704cc" > Stromal EGF and igf...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors

Castaño, Zafira (author)
Harvard University
Marsh, Timothy (author)
Tadipatri, Ramya (author)
show more...
Kuznetsov, Hanna S (author)
Al-Shahrour, Fatima (author)
Paktinat, Mahnaz (author)
Greene-Colozzi, April (author)
Nilsson, Björn (author)
Lund University,Lunds universitet,Avdelningen för hematologi och transfusionsmedicin,Institutionen för laboratoriemedicin,Medicinska fakulteten,Hematogenomics,Forskargrupper vid Lunds universitet,Division of Hematology and Transfusion Medicine,Department of Laboratory Medicine,Faculty of Medicine,Lund University Research Groups
Richardson, Andrea L (author)
McAllister, Sandra S (author)
show less...
 (creator_code:org_t)
2013
2013
English 14 s.
In: Cancer Discovery. - 2159-8274. ; 3:8, s. 922-935
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The causes for malignant progression of disseminated tumors and the reasons recurrence rates differ in women with different breast cancer subtypes are unknown. Here, we report novel mechanisms of tumor plasticity that are mandated by microenvironmental factors and show that recurrence rates are not strictly due to cell-intrinsic properties. Specifically, outgrowth of the same population of incipient tumors is accelerated in mice with triple-negative breast cancer (TNBC) relative to those with luminal breast cancer. Systemic signals provided by overt TNBCs cause the formation of a tumor-supportive microenvironment enriched for EGF and insulin-like growth factor-I (IGF-I) at distant indolent tumor sites. Bioavailability of EGF and IGF-I enhances the expression of transcription factors associated with pluripotency, proliferation, and epithelial-mesenchymal transition. Combinatorial therapy with EGF receptor and IGF-I receptor inhibitors prevents malignant progression. These results suggest that plasticity and recurrence rates can be dictated by host systemic factors and offer novel therapeutic potential for patients with TNBC.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

Animals
Antineoplastic Agents
Cell Line, Tumor
Cell Proliferation
Disease Progression
Epidermal Growth Factor
Epithelial-Mesenchymal Transition
Female
Gene Expression Regulation, Neoplastic
Humans
Insulin-Like Growth Factor I
Mice
Mice, Nude
Neoplasm Metastasis
Neoplasm Recurrence, Local
Neoplasm Transplantation
Receptor, Epidermal Growth Factor
Receptor, IGF Type 1
Stromal Cells
Transcription Factors
Triple Negative Breast Neoplasms
Tumor Microenvironment
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view